Advertisement

Psychopharmacology

, Volume 115, Issue 1–2, pp 135–140 | Cite as

μ-Opioid receptor and α2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts

  • Ane M. Gabilondo
  • J. Javier Meana
  • Fernando Barturen
  • Magdalena Sastre
  • Jesús A. García-Sevilla
Original Investigations

Abstract

The biochemical status of human brain μ-opioid receptors and α2-adrenoceptors during opiate dependence was studied by means of the binding of [3H] [D-Ala2, MePhe4, Gly-ol5] enkephalin (DAGO) and [3H]clonidine, respectively, in postmortem brains of heroin addicts who had died by opiate overdose or other causes. In the frontal cortex, thalamus and caudate of heroin addicts the density (Bmax) and affinity (KD) of μ-opioid receptors were similar to those in controls. In contrast, the density of α2-adrenoceptors in heroin addicts was found to be significantly decreased in frontal cortex (Bmax 31% lower), hypothalamus (Bmax 40% lower) and caudate (Bmax 32% lower) without changes in KD values. When heroin addicts were divided into two subgroups according to the presence or absence of morphine in body fluids, only the group with positive screening for morphine showed relevant decreases in brain α2-adrenoceptor density (Bmax 36–48% lower), whereas the decreases in receptor density observed in the subgroup with negative screening for morphine did not reach statistical significance. The results suggest that desensitization of brain α2A-adrenceptors is a relevant adaptative receptor mechanism during opiate addiction in humans.

Key words

Heroin addicts Postmortem human brain α2-Adrenoceptors μ-Opioid receptors Opiate addiction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and supression of withdrawal response by clonidine. Nature 276:186–188Google Scholar
  2. Aghajanian GK, Wang YY (1987) Common α2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 26:793–799Google Scholar
  3. Bartoletti M, Gaiardi M, Gubellini C, Bacchi A, Babbini M (1989) Cross-tolerance between morphine and clonidine: a study on motility in rats. Neuropharmacology 28:1159–1162Google Scholar
  4. Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lafkowitz RJ, Lomasney JW (1992) Pharmacological characteristics of α2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1–5Google Scholar
  5. Charney DS, Redmond DE Jr, Galloway MP, Kleber HD, Heninger GR, Murberg M, Roth RH (1984) Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Life Sci 35:1263–1272Google Scholar
  6. Collin E, Cesselin F (1991) Neurobiological mechanisms of opioid tolerance and dependence. Clin Neuropharmacol 14:465–488Google Scholar
  7. De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102Google Scholar
  8. De Vos H, Vauquelin G, De Keyser J, De Backer JP, Van Liefde I (1992) Regional distribution of α2A- and α2B-adrenoceptor subtypes in postmortem human brain. J Neurochem 58:1555–1560Google Scholar
  9. Done C, Silverstone P, Sharp T (1992) Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur J Pharmacol 215:333–336Google Scholar
  10. Duman RS, Tallman JF, Nestler EJ (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246:1033–1039Google Scholar
  11. Escribá PV, Sastre M, García-Sevilla JA (1993) Increased density of guanine nucleotide-binding (G) proteins in the frontal cortex of heroin addictys. Br J Pharmacol 108:30 PGoogle Scholar
  12. García-Sevilla JA, Ugedo L, Ulibarri I, Gutierrez M (1985) Platelet α2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine. Eur J Pharmacol 114:365–374Google Scholar
  13. García-Sevilla JA, Ulibarri I, Ugedo L, Gutierrez M (1987) α2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence. Psychopharmacology 92:320–323Google Scholar
  14. Hamburg M, Tallman JF (1981) Chronic morphine administration increases the apparent number of α2-adrenergic receptors in rat brain. Nature 291:493–495Google Scholar
  15. Korf J, Bunney BS, Aghajanian GK (1974) Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol 25: 165–169Google Scholar
  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  17. Lutfy K, Yoburn BC (1991) The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther 256:575–580Google Scholar
  18. Meana JJ, Barturen F, García-Sevilla JA (1989) Characterization and regional distribution of α2-adrenoceptors in postmortem human brain using the full agonist [3H] UK 14304. J Neurochem 52:1210–1217Google Scholar
  19. Meana JJ, Barturen F, García-Sevilla JA (1992) α2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 31:471–490Google Scholar
  20. Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239Google Scholar
  21. Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439–2450Google Scholar
  22. Nestler EJ, Erdos JJ, Terwilliger R, Duman RS, Tallman JF (1989) Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res 476:230–239Google Scholar
  23. Petrash AC, Bylund DB (1986) Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. Life Sci 38:2129–2137Google Scholar
  24. Puttfarcken PS, Cox BM (1989) Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci 45:1937–1942Google Scholar
  25. Raiteri M, Bonanno G, Maura G, Pende M, Andrioli GC, Ruelle A (1992) Subclassification of release-regulating α2-autoreceptors in human brain cortex. Br J Pharmacol 107:1146–1151Google Scholar
  26. Rogers NF, EI-Fakahany EE (1986) Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. Eur J Pharmacol 124: 221–230Google Scholar
  27. Sethy VH, Harris DW (1982) Effect of chronic morphine treatment on α2-adrenergic receptors in rat brain and spinal cord. Res Commun Subst Abuse 3: 121–124Google Scholar
  28. Smith CB, Hollingsworth PJ, Geer JJ, Moises HC (1983) Changes in α2-adrenoreceptros in various areas of the rat brain after long-term administration of “mu” and “kappa” opiate agonists. Life Sci 33 [suppl I]: 369–372Google Scholar
  29. Smith CB, Moises HC, Spengler RN, Hollingsworth PJ (1989) Changes in α2-adrenoceptor number and function in brains of morphine-dependent rats. Eur J Pharmacol 161:111–119Google Scholar
  30. Svensson TH, Bunney BS, Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res 92: 291–306Google Scholar
  31. Tempel A (1991) Visualization of μ opiate receptor downregulation following morphine treatment in neonatal rat brain. Dev Brain Res 64:19–26Google Scholar
  32. Ulibarri I, García-Sevilla JA, Ugedo L (1987) Modulation of brain α2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn-Schmiedeberg's Arch Pharmacol 336:530–537Google Scholar
  33. Van Vliet BJ, De Vries TJ, Wardeh G, Mulder AH, Schoffelmeer ANM (1991) μ-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur J Pharmacol Mol Pharmacol 208:105–111Google Scholar
  34. Vicentini LM, Miller RJ, Robertson MJ (1983) Chronic opiate treatment does not modify α2-adrenergic receptors in rat cerebral cortex, kidney and in the neurotumor cell line NCB20. Eur J Pharmacol 95:265–270Google Scholar
  35. Werling LL, McMahon PN, Cox BM (1988) Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex. J Pharmacol Exp Ther 247:1103–1106Google Scholar
  36. Werling LL, McMahon PN, Cox BM (1989) Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393–6397Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Ane M. Gabilondo
    • 1
  • J. Javier Meana
    • 1
  • Fernando Barturen
    • 1
  • Magdalena Sastre
    • 2
  • Jesús A. García-Sevilla
    • 2
  1. 1.Department of PharmacologyUniversity of the Basque CountryLeioa, BizkaiaSpain
  2. 2.Laboratory of Neuropharmacology, Department of Fundamental Biology and Health SciencesUniversity of the Balearic IslandsPalma de MallorcaSpain

Personalised recommendations